Adjuvant chemotherapy for T3 prostate cancer: not ready for prime time

Ten-year survival rates by PSA nadir in patients with metastatic hormone-sensitive prostate cancer: long-term survival analysis from the ECOG-ACRIN 3805 (CHAARTED) trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Muscadine Grape Skin Extract in Biochemically Recurrent Prostate Cancer: A Randomized, Placebo-Controlled, Biomarker-Enriched Trial in Patients With the SOD2 Ala/Ala Variant.

The Prostate·2025

LSD1 inhibition suppresses ASCL1 and de-represses YAP1 to drive potent activity against neuroendocrine prostate cancer.

bioRxiv : the preprint server for biology·2024

Transcriptional profiling of primary prostate tumor in metastatic hormone-sensitive prostate cancer and association with clinical outcomes: correlative analysis of the E3805 CHAARTED trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Transforming the Perioperative Treatment Paradigm in Non-Metastatic RCC-A Possible Path Forward.

Kidney cancer (Clifton, Va.)·2018

A review of pomegranate in prostate cancer.

Prostate cancer and prostatic diseases·2017

Rising active surveillance rates/observation and regimen intensification in young men: A retrospective cohort study of national commercial health insurance claims data.

Urology·2026

The Effect Of Metronome Rhythm On Pain, Anxiety, And Patient Experience During Cystoscopy: A Prospective Clinical Study.

Urology·2026

Safety of Right-Sided Minimally Invasive Living Donor Nephrectomy: A Contemporary National Registry Analysis of 29,874 Transplants.

Urology·2026

Telehealth in Urologic Oncology: Temporal Trends and Patient Characteristics in the United States.

Urology·2026

Benign Prostatic Hyperplasia Pharmacotherapy and Incident Ocular Surface Disease: Comparative Risk of Alpha-Blockers Versus 5-Alpha Reductase Inhibitors.

Urology·2026

Firearm-Related External Genital Trauma: Contemporary Management Strategies and Outcomes to Inform Urologic Trauma Guidelines.

Urology·2026

Functional Brain Network Alterations Linked to Cancer-Related Cognitive Impairment in Breast Cancer Patients.

The oncologist·2026

A phase II multi-institutional single arm trial evaluating TG4010 vaccine plus nivolumab in non-small cell lung cancer.

Oncoimmunology·2026

Intravesical gemcitabine versus Bacillus Calmette-Guérin (BCG) for intermediate-/high-risk non-muscle-invasive bladder cancer during the BCG shortage: Safety, efficacy, and health-economic context.

Investigative and clinical urology·2026

Feasibility of Single-Session Whole-Liver Yttrium-90 Radioembolization for Multifocal Hepatocellular Carcinoma.

Korean journal of radiology·2026

Cemiplimab in cutaneous squamous cell carcinoma: a longer follow-up study focusing on the late toxicities.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026

Not all anti-CD38 antibodies are created equal: The epitope of felzartamab is partially DTT-resistant.

Transfusion medicine (Oxford, England)·2026

Related Experiment Videos

Adjuvant chemotherapy for T3 prostate cancer: not ready for prime time

Related Concept Videos

Ten-year survival rates by PSA nadir in patients with metastatic hormone-sensitive prostate cancer: long-term survival analysis from the ECOG-ACRIN 3805 (CHAARTED) trial.

Muscadine Grape Skin Extract in Biochemically Recurrent Prostate Cancer: A Randomized, Placebo-Controlled, Biomarker-Enriched Trial in Patients With the SOD2 Ala/Ala Variant.

LSD1 inhibition suppresses ASCL1 and de-represses YAP1 to drive potent activity against neuroendocrine prostate cancer.

Transcriptional profiling of primary prostate tumor in metastatic hormone-sensitive prostate cancer and association with clinical outcomes: correlative analysis of the E3805 CHAARTED trial.

Transforming the Perioperative Treatment Paradigm in Non-Metastatic RCC-A Possible Path Forward.

A review of pomegranate in prostate cancer.

Rising active surveillance rates/observation and regimen intensification in young men: A retrospective cohort study of national commercial health insurance claims data.

The Effect Of Metronome Rhythm On Pain, Anxiety, And Patient Experience During Cystoscopy: A Prospective Clinical Study.

Safety of Right-Sided Minimally Invasive Living Donor Nephrectomy: A Contemporary National Registry Analysis of 29,874 Transplants.

Telehealth in Urologic Oncology: Temporal Trends and Patient Characteristics in the United States.

Benign Prostatic Hyperplasia Pharmacotherapy and Incident Ocular Surface Disease: Comparative Risk of Alpha-Blockers Versus 5-Alpha Reductase Inhibitors.

Firearm-Related External Genital Trauma: Contemporary Management Strategies and Outcomes to Inform Urologic Trauma Guidelines.

Functional Brain Network Alterations Linked to Cancer-Related Cognitive Impairment in Breast Cancer Patients.

A phase II multi-institutional single arm trial evaluating TG4010 vaccine plus nivolumab in non-small cell lung cancer.

Intravesical gemcitabine versus Bacillus Calmette-Guérin (BCG) for intermediate-/high-risk non-muscle-invasive bladder cancer during the BCG shortage: Safety, efficacy, and health-economic context.

Feasibility of Single-Session Whole-Liver Yttrium-90 Radioembolization for Multifocal Hepatocellular Carcinoma.

Cemiplimab in cutaneous squamous cell carcinoma: a longer follow-up study focusing on the late toxicities.

Not all anti-CD38 antibodies are created equal: The epitope of felzartamab is partially DTT-resistant.

Related Experiment Videos

Adjuvant chemotherapy for T3 prostate cancer: not ready for prime time

Related Concept Videos

Related Articles